Publication | Open Access
SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY
128
Citations
24
References
2015
Year
In eyes with persistent SRF due to central serous chorioretinopathy, spironolactone significantly reduced both the SRF and the subfoveal choroidal thickness as compared with placebo.
| Year | Citations | |
|---|---|---|
Page 1
Page 1